Table 4.
Antiproliferative activity of isolated metabolites against H1650, HL-60, and HT-29 cancer cells.
| Tested Compounds | IC50 ± S.D. (μM)a | ||
|---|---|---|---|
| H1650 | HL-6 | HT-29 | |
| 1 | >100 | 2.8 ± 0.74 | 3.6 ± 0.55 |
| 2 | >100 | >100 | >100 |
| 3 | >100 | 4.2 ± 0.23 | 3.7 ± 0.31 |
| 4 | >100 | >100 | >100 |
| 5 | >100 | >100 | >100 |
| 6 | >100 | >100 | >100 |
| 7 | >100 | >100 | >100 |
| 8 | >100 | >100 | >100 |
| 9 | >100 | >100 | >100 |
| 10 | >100 | >100 | >100 |
| 11 | >100 | >100 | >100 |
| 5-Flurouracil | 0.5 ± 0.67 | 0.2 ± 0.43 | 0.3 ± 0.35 |
Values are a mean of 3 independent experiments.